The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Cost Effectiveness of Simvastatin Treatment to Lower Cholesterol Levels in Patients with Coronary Heart Disease
Open accessAbstract
BACKGROUND: The Scandinavian Simvastatin Survival Study (4S) showed that lowering cholesterol levels with simvastatin reduces mortality and morbidity in patients with angina pectoris or previous acute myocardial infarction. Before the widespread use of cholesterol-lowering drugs in such patients is recommended, its cost effectiveness should be demonstrated. We estimated the cost effectiveness of simvastatin treatment to lower cholesterol levels in relation to the age, sex, and cholesterol level before treatment of patients with coronary heart disease. METHODS: We estimated the cost per year of life gained with simvastatin therapy. To model the increased life expectancy, hazard functions from 4S were used. The costs studied included those of the intervention and the direct and indirect costs associated with morbidity from coronary causes. We prepared separate estimates for men and women at various ages (from 35 to 70 years) and total cholesterol levels before treatment (213 to 309 mg per deciliter). RESULTS: In the analysis limited to direct costs, the cost of each year of life gained ranged from $3,800 for 70-year-old men with 309 mg of cholesterol per deciliter to $27,400 for 35-year-old women with 213 mg of cholesterol per deciliter. When we included indirect costs, the results ranged from a savings in the youngest patients to a cost of $13,300 per year of life gained in 70-year-old women with 213 mg of cholesterol per deciliter. CONCLUSIONS: In patients with coronary heart disease, simvastatin therapy is cost effective among both men and women at the ages and cholesterol levels studied.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Foundations of Cost-Effectiveness Analysis for Health and Medical Practices
Weinstein, M. C., & Stason, W. B. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703312961304 · Cited by 2,119
LaRosa, J. C., Hunninghake, D., Bush, D., Criqui, M. H., Getz, G. S., Gotto, A. M., Grundy, S. M., Rakita, L., Robertson, R. M., & Weisfeldt, M. L. (1990) · Circulation · doi:10.1161/01.cir.81.5.1721 · Cited by 556
Mark, D. B., Hlatky, M. A., Califf, R. M., Naylor, C. D., Lee, K. L., Armstrong, P. W., Barbash, G., White, H., Simoons, M. L., Nelson, C. L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322106 · Cited by 521
Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)
Scandinavian Simvastation Survival Study Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)90926-5 · Cited by 255
Gillespie, K. N. (1987) · American Political Science Review · doi:10.2307/1962759 · Cited by 249
Principles of Cost-Effective Resource Allocation in Health Care organizations
Weinstein, M. C. (1990) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300008953 · Cited by 222
Tosteson, A. N. A., Rosenthal, D. I., Melton, L. J., & Weinstein, M. C. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-8-594 · Cited by 221
Pedersen, T. R., Kjekshus, J., Berg, K., Olsson, A. G., Wilhelmsen, L., Wedel, H., Pyörälä, K., Miettinen, T., Haghfelt, T., Færgeman, O., et al. (1996) · Circulation · doi:10.1161/01.cir.93.10.1796 · Cited by 197
Self-citationStability of Time-tradeoff Utilities in Survivors of Myocardial Infarction
Tsevat, J., Goldman, L., Soukup, J. R., Lamas, G. A., Connors, K. F., Chapin, C. C., & Lee, T. H. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300210 · Cited by 197
Cited by
An Introduction to Markov Modelling for Economic Evaluation
Briggs, A., & Sculpher, M. (1998) · PharmacoEconomics · doi:10.2165/00019053-199813040-00003 · Cited by 960
Jousilahti, P., Vartiainen, E., Tuomilehto, J., & Puska, P. (1999) · Circulation · doi:10.1161/01.cir.99.9.1165 · Cited by 890
Athyros, V. G., Papageorgiou, A. A., Mercouris, B. R., Athyrou, V. V., Symeonidis, A. N., Basayannis, E. O., Demitriadis, D. S., & Kontopoulos, A. G. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000787 · Cited by 533
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Palmer, S. C., Navaneethan, S. D., Craig, J. C., Johnson, D. W., Perkovic, V., Hegbrant, J., & Strippoli, G. F. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007784.pub2 · Cited by 331
Rauch, B., Davos, C. H., Doherty, P., Saure, D., Metzendorf, M.-I., Salzwedel, A., Völler, H., Jensen, K., Schmid, J.-P., & on behalf of the ‘Cardiac Rehabilitation Section’, E. A. O. P. C. (. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316671181 · Cited by 316
Metadata
- Authors
- Johannesson, M., Jönsson, B., Kjekshus, J., Olsson, A. G., Pedersen, T. R., & Wedel, H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1997-01-30
- Volume
- 336
- Issue
- 5
- Pages
- 332-336
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2341112456
- Cited by
- 387
- References
- 17
- FWCI
- 45.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost Effectiveness of Simvastatin Treatment to Lower Cholesterol Levels in Patients with Coronary Heart Disease. https://app.cochat.ai/papers/10.1056/nejm199701303360503
- The paper
- Johannesson, M., Jönsson, B., Kjekshus, J., Olsson, A. G., Pedersen, T. R., & Wedel, H. (1997). Cost Effectiveness of Simvastatin Treatment to Lower Cholesterol Levels in Patients with Coronary Heart Disease. New England Journal of Medicine. https://doi.org/10.1056/nejm199701303360503
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.